Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    22432104 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Lixisenatide (AVE0010);   Drug: Placebo;   Device: Pen auto-injector
2 Recruiting Drug Trial of Lixisenatide on Gastric Emptying and Blood Pressure Drops in Type 2 Diabetics and Healthy People
Conditions: Diabetes Mellitus;   Gastroparesis
Interventions: Drug: Lixisenatide;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.